Brief: Pharmasimple Cancels Publication Of Q1 Turnover
May 10 (Reuters) - PHARMASIMPLE SA ALPHS.PA :
* INFORMS FINANCIAL COMMUNITY OF CANCELLATION OF PUBLICATION
OF
ITS QUARTERLY TURNOVER
* DUE TO THE IMPLEMENTATION OF PHARMASIMPLE'S NEW
DEVELOPMENT
STRATEGY BASED ON MAJOR PHARMACY ACQUISITIONS, WHICH IS
CURRENTLY UNDERWAY
* WILL PRESENT TURNOVER OF H1 ON 27 JULY 2022
Source text for Eikon: ID:nACT74556
Further company coverage: ALPHS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months